Stoke Therapeutics Inc - as of March 31, 2024, Company Had $178.6 Mln in Cash and Cash Equivalents
Stoke Therapeutics Inc——截至2024年3月31日,公司拥有1.786亿美元的现金及现金等价物
Stoke Therapeutics Inc - as of March 31, 2024, Company Had $178.6 Mln in Cash and Cash Equivalents
Stoke Therapeutics Inc——截至2024年3月31日,公司拥有1.786亿美元的现金及现金等价物
使用浏览器的分享功能,分享给你的好友吧